
Jeffrey L. Curtis
307 posts

Jeffrey L. Curtis
@jlcaa_l
Physician-scientist
Ann Arbor, MI Katılım Ekim 2014
95 Takip Edilen79 Takipçiler

Makes total sense if you have the privilege of working here. lnkd.in/g3iK_C2C
English
Jeffrey L. Curtis retweetledi

Thank you Wassim Labaki for nominating me for the @ATSCPAssembly award. I’m the one who is lucky to have you as a mentee! Thanks also to my mentor Fernando Martinez for teaching so well. @MichiganPulmCC

English

@lindsayadmon @jamie_daw @UM_IHPI @UM_PWHER @UMichCHOPFellow @Dee_Fenner_MD @ColumbiaMSPH @columbiahpm @PublicHealthUMN @UMNRHRC @VUMCchildpolicy @AHRQNews Great news, Lindsay, as long as you do so from Ann Arbor.
English

Such an important message from my colleagues. lnkd.in/gaR8kQTb
English

Congratulations, Francesca Polverino on winning the 2022 ERS MID-CAREER GOLD MEDAL IN COPD
Francesca Polverino, MD, PhD, has done major contributions to the field of COPD pathogenesis. At the age of 34, Francesca became a faculty member at Harvard Medica…lnkd.in/gDE9ZR2D
English

Please read this World view piece in Nature 23 June 2022. lnkd.in/gB8pguXF
English

Insufficiently appreciated fact: air pollution kills. lnkd.in/eMZff_Fm
English

Another insight into the amazing life of tissue-resident #macrophages #innate immunity #obesity #diabetes lnkd.in/gnG6U9DR
English
Jeffrey L. Curtis retweetledi

I’m very excited that the VA Ann Arbor Healthcare System has been chosen to join the VA Cooperative Studies Program’s (CSP) network of designated enrollment sites (NODES).
This program will increase our ability to bring cutting-edge clinical research op…lnkd.in/gZdGSdbF
English

Delighted by the acceptance of the latest paper from the Curtis-Freeman lab at VA Ann Arbor/University of Michigan Graduate Program in Immunology. #COPD #copdawareness #lungdisease #nkcells #immunology #universityofmichigan #goblue #MichiganMedicine ow.ly/GKMa50H4K5v
English

@JamesBeck_MD @atscommunity @VAECHCS Dear Jim @JamesBeck_MD : congratulations and best wishes. You’ve made huge contributions to VA, @atscommunity and biomedical science worldwide.
English

Dear @atscommunity , tomorrow I will be retiring from @VAECHCS after 31 1/2 years of VA service. It’s been the honor of my career to care for Veterans in PA, CA, MI, and CO. I’ll continue my involvement with @atscommunity including chairing our Task Force on Governance.
Denver, CO 🇺🇸 English
Jeffrey L. Curtis retweetledi

Every year, more than 156,000 Americans die from #COPD. It’s important that we better understand this disease and its impact on Americans, so that we can find solutions to save lives. Lung.org/copd-trends

English
Jeffrey L. Curtis retweetledi

1/ Dr. Tobin fought #Racism toward #Truth at #GeorgeFloyd’s Trial: NYTs & Video 🎥 (tw 3)
Our friend & Iconic colleague testified to fact that #DerekChauvin’s knee killed Mr. Floyd by Asphyxiation, He used #Science.
nyti.ms/3uy8UaC
#medtwitter #nursetwitter #justice
English

@jamesbeck_ATS @atscommunity @PACCM Janet: congratulations, so well deserved. You’re an awesome scientist.
English

Congratulations, Janet, from the @atscommunity Executive Committee. We appreciate your huge contributions to our Society! @PACCM
PACCSM@PACCSM
Congratulations, Dr. Janet Lee! 2020 ATS Respiratory Health Awardee-Recognition Award for Scientific Accomplishments! @PittDeptofMed @PACCM_fellows
Colorado, USA 🇺🇸 English

@FrankS1956 @realmdransfield @NEJM Proud to have worked with @realmdransfield, @FrankS1956, and other esteemed colleagues on this landmark study. The community now needs to learn if those w/ COPD who DO have a solid indication for beta-blockers also suffer more exacerbations. COPD is treatable and preventable.
English

Our group led by @realmdransfield at #Chest2019 and @NEJM showed in #COPD pts, w/o other indication, beta blockers do not prevent exacerbation but increase risk for hospitalization (HR 1.91). Risk/benefit UNKNOWN in COPD pts w cardiovascular indication!?
NEJM@NEJM
In this randomized trial involving patients with moderate or severe #COPD, treatment with the beta-blocker metoprolol did not result in a shorter time until the first COPD exacerbation than placebo. #CHEST2019 nej.md/2P5nANc
English

